Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Interleukin 2”

462 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 462 results

Testing effectiveness (Phase 2)UnknownNCT00080977
What this trial is testing

High-Dose Intravenous Interleukin-2 in Treating Patients With Metastatic Renal Cell Carcinoma (Kidney Cancer) That Has Not Responded to Previous Low-Dose Intravenous or Subcutaneous Interleukin-2

Who this might be right for
Kidney Cancer
Blumenthal Cancer Center at Carolinas Medical Center
Testing effectiveness (Phase 2)UnknownNCT04062006
What this trial is testing

Low-dose Interleukin-2 Treatment on Polymyalgia Rheumatica

Who this might be right for
Polymyalgia Rheumatica
Peking University People's Hospital 15
Testing effectiveness (Phase 2)UnknownNCT00003181
What this trial is testing

Interleukin-2, Vinblastine, and GM-CSF in Treating Patients With Metastatic Kidney Cancer

Who this might be right for
Kidney Cancer
Hope Cancer Institute, Inc. 35
Testing effectiveness (Phase 2)WithdrawnNCT01833767
What this trial is testing

Low-dose Cyclophosphamide and Outpatient IV Interleukin-2 in Metastatic Melanoma

Who this might be right for
Metastatic Melanoma
Western Regional Medical Center
Large-scale testing (Phase 3)Ended earlyNCT00147355
What this trial is testing

Toxicity Substudy of Evaluation of Subcutaneous Proleukin in a Randomised International Trial (ESPRIT): TOXIL-2 Substudy

Who this might be right for
HIV Infections
Kirby Institute 28
Testing effectiveness (Phase 2)UnknownNCT00002847
What this trial is testing

Interferon Alfa and Interleukin-2 in Treating Patients With Metastatic Kidney Cancer

Who this might be right for
Kidney Cancer
Blumenthal Cancer Center at Carolinas Medical Center 14
Not applicableStudy completedNCT00001353
What this trial is testing

Safety and Survival of Genetically Modified White Blood Cells in HIV-Infected Persons - A Study in Identical Twin Pairs

Who this might be right for
Acquired Immunodeficiency SyndromeHIV Infection
National Institute of Allergy and Infectious Diseases (NIAID) 24
Testing effectiveness (Phase 2)Looking for participantsNCT05086692
What this trial is testing

A Beta-only IL-2 ImmunoTherapY Study

Who this might be right for
Advanced Solid TumorUnresectable Solid TumorClear Cell Renal Cell Carcinoma+34 more
Medicenna Therapeutics, Inc. 115
Testing effectiveness (Phase 2)Study completedNCT03312335
What this trial is testing

Low-dose Interleukin-2 for Treatment of Systemic Lupus Erythematosus

Who this might be right for
Lupus Erythematosus, Systemic
Onur Boyman, MD 16
Post-approval studies (Phase 4)UnknownNCT04766307
What this trial is testing

A New Treatment for Primary Smear-positive Pulmonary Tuberculosis With Interleukin-2

Who this might be right for
Tuberculosis, Pulmonary
Beijing Chest Hospital 1,100
Early research (Phase 1)Study completedNCT00110578
What this trial is testing

Safety and Effectiveness of Immunotherapy With Autologous HIV-Specific CD8 Cells in HIV Infected Adults

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 24
Early research (Phase 1)Study completedNCT00529035
What this trial is testing

Ultra-Low Dose Interleukin-2 for Refractory Chronic Graft Versus Host Disease

Who this might be right for
Graft Versus Host Disease
Dana-Farber Cancer Institute 29
Early research (Phase 1)Ended earlyNCT00091611
What this trial is testing

Cultured White Cells Plus Interleukin-2 to Treat Advanced Kidney Cancer

Who this might be right for
Kidney Neoplasms
National Cancer Institute (NCI) 3
Early research (Phase 1)Study completedNCT00000728
What this trial is testing

Phase I Trial of the Combination of Zidovudine and Recombinant Interleukin-2 in Patients With Persistent Generalized Lymphadenopathy

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 20
Testing effectiveness (Phase 2)Study completedNCT01480323
What this trial is testing

A Phase II Study to Evaluate Safety and Efficacy of Combined Treatment With Ipilimumab and Intratumoral Interleukin-2

Who this might be right for
Malignant Melanoma
University Hospital Tuebingen 15
Early research (Phase 1)Study completedNCT04916431
What this trial is testing

Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of mRNA-6231 in Healthy Adults

Who this might be right for
Healthy Volunteers
ModernaTX, Inc. 18
Testing effectiveness (Phase 2)Study completedNCT00001475
What this trial is testing

Home Treatment of HIV-Infected Patients With Interleukin-2 With or Without a Tumor Necrosis Factor Antagonist

Who this might be right for
Acquired Immunodeficiency SyndromeHIV Infection
National Institute of Allergy and Infectious Diseases (NIAID) 85
Testing effectiveness (Phase 2)Study completedNCT00043667
What this trial is testing

Daclizumab Injections to Treat Non-Infectious Sight-Threatening Uveitis

Who this might be right for
Uveitis
National Eye Institute (NEI) 15
Testing effectiveness (Phase 2)Study completedNCT00006264
What this trial is testing

Zidovudine Plus Interleukin-2 and Ganciclovir in Treating Patients With AIDS-Related Primary Central Nervous System Lymphoma

Who this might be right for
Lymphoma
AIDS Malignancy Consortium
Very early researchStudy completedNCT00276835
What this trial is testing

Genistein and Interleukin-2 in Treating Patients With Metastatic Melanoma or Kidney Cancer

Who this might be right for
Kidney CancerMelanoma (Skin)
Northwestern University 15
Load More Results